A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
Background: With the goal of global eradication of poliomyelitis due to wild-type viruses within sight, WHO now recommends that infants receive at least one dose of trivalent inactivated poliovirus vaccine (IPV) with bivalent OPV (types 1 and 3) replacing trivalent OPV. Limited manufacturing capacit...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2018-12-01
|
| סדרה: | Human Vaccines & Immunotherapeutics |
| נושאים: | |
| גישה מקוונת: | http://dx.doi.org/10.1080/21645515.2018.1504538 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|